Moderna
MRNA
#1236
Rank
A$22.58 B
Marketcap
$58.69
Share price
3.55%
Change (1 day)
-50.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of September 2024 : A$10.53 Billion

According to Moderna 's latest financial reports the company has A$10.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$12.62 B-13.21%
2022-12-31A$14.55 B-1.66%
2021-12-31A$14.79 B146.9%
2020-12-31A$5.99 B280.4%
2019-12-31A$1.57 B-27.05%
2018-12-31A$2.15 B123.01%
2017-12-31A$0.96 B-34.03%
2016-12-31A$1.46 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.14 B-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.38 B 112.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.56 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.26 B-59.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.51 B 104.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$0.66 B-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$31.14 B 195.57%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA